Am. Doherty et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF C-TERMINAL ENDOTHELIN HEXAPEPTIDEANTAGONISTS, Journal of medicinal chemistry, 36(18), 1993, pp. 2585-2594
The discovery of selective endothelin (ET) receptor antagonists will f
acilitate identification of the physiological and pathological roles f
or ET and its isopeptides. Structure-activity studies of the C-termina
l hexapeptide of ET have been carried out to elucidate those amino aci
ds important for receptor binding and agonist or antagonist activity.
Binding studies were performed in rat heart ventricle, rabbit renal ar
tery vascular smooth muscle cells, and rat cerebellum. In addition, ma
ny of the compounds have been evaluated functionally for their effects
on endothelin-1-induced arachidonic acid release and inositol phospha
te accumulation in specific cell lines. Selected compounds have been e
valuated in a functional bioassay in tissue preparations specifically
expressing either ET(A) or ET(B) receptors. We have previously describ
ed the structure-activity relationships in the hydrophobic C-terminal
hexapeptide of ET, a region known to be highly important for receptor
recognition. A mono-D-amino acid scan of the ET[16-21] revealed that s
ubstitution at His16 gave rise to analogs with significantly enhanced
binding affinity. We have further evaluated the C-terminal region and
will describe the design, synthesis, and pharmacological evaluation of
several novel and potent ET peptide receptor antagonists.